Retrieve Medical Holdings Debt to Equity Ratio 2012-2025 | RMHI
Current and historical debt to equity ratio values for Retrieve Medical Holdings (RMHI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Retrieve Medical Holdings debt/equity for the three months ending September 30, 2025 was 0.00.
| Retrieve Medical Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.01B | $-0.01B | -1.03 |
| 2025-06-30 | $0.01B | $0.00B | -1.12 |
| 2025-03-31 | $0.01B | $-0.01B | -1.01 |
| 2024-12-31 | $0.00B | $0.00B | -1.02 |
| 2024-09-30 | $0.00B | $0.00B | -1.02 |
| 2024-06-30 | $0.00B | $0.00B | -1.02 |
| 2024-03-31 | $0.00B | $0.00B | -1.03 |
| 2023-12-31 | $0.00B | $0.00B | -1.02 |
| 2023-09-30 | $0.00B | $0.00B | -1.02 |
| 2023-06-30 | $0.00B | $0.00B | -1.02 |
| 2023-03-31 | $0.00B | $0.00B | -1.06 |
| 2022-12-31 | $0.00B | $0.00B | -1.03 |
| 2022-09-30 | $0.00B | $0.00B | -1.27 |
| 2022-06-30 | $0.00B | $0.00B | -1.31 |
| 2022-03-31 | $0.00B | $0.00B | -1.41 |
| 2021-12-31 | $0.00B | $0.00B | -1.50 |
| 2021-09-30 | $0.00B | $0.00B | -1.80 |
| 2021-06-30 | $0.00B | $0.00B | -1.13 |
| 2021-03-31 | $0.00B | $0.00B | -1.00 |
| 2020-12-31 | $0.00B | $0.00B | -1.00 |
| 2020-09-30 | $0.00B | $0.00B | -1.00 |
| 2020-06-30 | $0.00B | $0.00B | -1.00 |
| 2020-03-31 | $0.00B | $0.00B | -1.00 |
| 2019-12-31 | $0.00B | $0.00B | -1.00 |
| 2019-09-30 | $0.00B | $0.00B | -1.00 |
| 2019-06-30 | $0.00B | $0.00B | -1.00 |
| 2019-03-31 | $0.00B | $0.00B | -1.00 |
| 2018-12-31 | $0.00B | $0.00B | -1.00 |
| 2018-09-30 | $0.00B | $0.00B | -1.01 |
| 2018-06-30 | $0.00B | $0.00B | -1.08 |
| 2018-03-31 | $0.00B | $0.00B | -1.02 |
| 2017-12-31 | $0.00B | $0.00B | -1.01 |
| 2017-09-30 | $0.00B | $0.00B | -1.02 |
| 2017-06-30 | $0.00B | $0.00B | -1.06 |
| 2017-03-31 | $0.00B | $0.00B | -1.14 |
| 2016-12-31 | $0.00B | $0.00B | -1.01 |
| 2016-09-30 | $0.00B | $0.00B | -1.01 |
| 2016-06-30 | $0.00B | $0.00B | -1.01 |
| 2016-03-31 | $0.00B | $0.00B | -1.02 |
| 2015-12-31 | $0.00B | $0.00B | -3.14 |
| 2015-09-30 | $0.00B | $0.00B | -39.53 |
| 2015-06-30 | $0.00B | $0.00B | 4.34 |
| 2015-03-31 | $0.00B | $0.00B | 1.14 |
| 2014-12-31 | $0.00B | $0.00B | 0.61 |
| 2014-09-30 | $0.00B | $0.00B | 0.13 |
| 2014-06-30 | $0.00B | $0.00B | 1.59 |
| 2014-03-31 | $0.00B | $0.00B | -1.28 |
| 2013-12-31 | $0.00B | $0.00B | -2.34 |
| 2013-09-30 | $0.00B | $0.00B | -1.13 |
| 2013-06-30 | $0.00B | $0.00B | -1.28 |
| 2013-03-31 | $0.00B | $0.00B | -1.40 |
| 2012-12-31 | $0.00B | $0.00B | -1.63 |
| 2012-09-30 | $0.00B | $0.00B | -1.31 |
| 2012-06-30 | $0.00B | $0.00B | -1.48 |
| 2012-03-31 | $0.00B | $0.00B | -2.55 |
| 2011-12-31 | $0.00B | $0.00B | -1.76 |
| 2011-09-30 | $0.00B | $0.00B | 2.13 |
| 2011-06-30 | $0.00B | $0.00B | 102.00 |
| 2011-03-31 | $0.00B | $0.00B | 3.12 |
| 2010-12-31 | $0.00B | $0.00B | 1.63 |
| 2010-09-30 | $0.00B | $0.00B | 0.97 |
| 2010-06-30 | $0.00B | $0.00B | 0.33 |
| 2010-03-31 | $0.00B | $0.00B | 0.17 |
| 2009-12-31 | $0.00B | $0.00B | 0.17 |
| 2009-09-30 | $0.00B | $0.00B | 0.45 |
| 2009-06-30 | $0.00B | $0.00B | -2.18 |
| 2009-03-31 | $0.00B | $0.00B | -10.91 |
| 2008-12-31 | $0.00B | $0.00B | 1.36 |
| 2008-09-30 | $0.00B | $0.00B | 0.35 |
| 2008-06-30 | $0.00B | 0.00 | |
| 2008-03-31 | $0.00B | 0.00 | |
| 2007-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.049B | $0.000B |
| Retrieve Medical Inc. is a software company. It is commercializing a patented Clinical Documentation Improvement platform, Retrieve Dx(TM), which enhances physician ability to quickly understand the complex clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results, radiology reports, EKG interpretations and more. Retrieve Medical Inc., formerly known as Peak Pharmaceuticals Inc., is based in SCOTTSDALE, AZ. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.549B | 41.11 |
| Tempus AI (TEM) | United States | $11.881B | 0.00 |
| Doximity (DOCS) | United States | $7.738B | 31.86 |
| Hims & Hers Health (HIMS) | United States | $6.936B | 56.43 |
| IRHYTHM HLDGS (IRTC) | United States | $5.335B | 0.00 |
| Hinge Health (HNGE) | United States | $3.276B | 0.00 |
| Heartflow (HTFL) | United States | $2.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.855B | 178.54 |
| 10x Genomics (TXG) | United States | $2.791B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.744B | 45.41 |
| Omnicell (OMCL) | United States | $2.202B | 45.01 |
| Azenta (AZTA) | United States | $1.818B | 74.57 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Enovis (ENOV) | United States | $1.321B | 6.93 |
| Schrodinger (SDGR) | United States | $1.202B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.043B | 0.00 |
| Phreesia (PHR) | United States | $0.948B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.856B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.471B | 0.00 |
| Evolent Health (EVH) | United States | $0.440B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.353B | 0.00 |
| Carlsmed (CARL) | United States | $0.337B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.302B | 13.86 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.290B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.176B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.156B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.092B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.069B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.064B | 0.00 |
| 111 (YI) | China | $0.044B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.039B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.020B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.012B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |